Cargando...
Gene editing and gene-based therapeutics for cardiomyopathies
With an increasing understanding of genetic defects leading to cardiomyopathy, focus is shifting to methods for correcting these underlying genetic defects. One approach involves treating mutant RNA through antisense oligonucleotides, and the first drug has now received regulatory approval to treat...
Gardado en:
| Publicado en: | Heart Fail Clin |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849064/ https://ncbi.nlm.nih.gov/pubmed/29525646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hfc.2017.12.006 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|